References
- Covelli I., Wolff J. Iodohistidine formation in ribonuclease A. J. biol. Chem. 1966; 241: 4444
- Gordon J., Rose B., Sehon A. H. Detection of 'non‐precipitating' antibodies in sera of individuals allergic to ragweed pollen by an in vitro method. J. exp. Med. 1958; 108: 37
- Greenwood F. C., Hunter W. M., Glover J. S. The preparation of 131I‐labelled human growth hormone of high specific radioactivity. Biochem, J. 1963; 89: 114
- Hunter W. M., Greenwood F. C. Preparation of iodine‐131 labelled human growth hormone of high specific activity. Nature 1962; 194: 495
- Li C. H. Kinetics of reactions between iodine and histidine. J. Am. Chem. Soc. 1944; 66: 225
- Ling N., Leppäluoto J., Vale W. Chemical, biological and immunological characterization of mono‐ and diiodothyrotropin releasing factor. Anal. Biochem. 1976; 16: 125
- Oliver G. C., Jr., Parker B. M., Brasfield D. L., Parker C. W. The measurement of digitoxin in human serum by radioimmunoassay. J. clin. Invest. 1968; 47: 1035
- Pauly H., Gunderman K. Übern jodbindende Systeme in den Eiweiss‐ Spaltkörpen. Ber. Bun senges Phys. Chern. 1908; 41: 3999
- Puurunen J., Ruskoaho H., Kärki N. T., Karjalainen A., Kurkela K. A comparative study on hypotensive and bradycardic effects of some new imidazole derivatives with possible central mechanism of action. Arch. Int. Pharmacodyn. Ther. 1983; 261: 102
- Ruskoaho H., Savola J. ‐M., Kaipiainen S., Puurunen J., Kärki N. The cardiovascular effects of MPV‐295 ‘4(5)‐2‐(2.6‐dimethyIphenyl)‐ethylimidazole’, a new antihypertensive agent with α2adrenoceptor agonistic properties. Naunyn Schmiedebergs Arch. Pharmacol. 1983; 322: 279
- Tantchou J. K., Slaunwhite W. R., Jr. The synthesis of 125 I‐2–iodohistamine for radioimmunoassay. Prep. Biochem. 1979; 9: 379
- Vaughan J. D., Lambert D. G., Vaughan V. L. Kinetics and mechanism of iodination of pyrazole. Comparative reactivities of pyrazole and imidazole. J. Am. Chem. Soc. 1964; 86: 2857